The corporate, which produces and distributes the coronavirus vaccine worldwide, along with the American pharmaceutical firm Pfizer, introduced that the outcomes of the exams they carried out on children may come till September.
FIRST VACCINE TO BE AUTHORIZED
The BioNTech-Pfizer vaccine grew to become the primary globally licensed for ages 16 and over on the finish of final yr, and the primary to obtain the inexperienced mild from the US and European Union for children ages 12 to 16 this Could.
In Germany, nevertheless, this method is not really useful by the Standing Vaccination Fee (Stiko) for all children aged 12 to 16 years, however solely for children with pre-existing diseases for whom coronavirus an infection could pose a selected threat.
German firm BioNTech and Pfizer introduced that they’ve progressively began exams in children underneath the age of 12 this yr, in accordance to age teams, so as to confirm the effectiveness of their vaccines in several teams and on the required doses.
The pharmaceutical firm additionally plans to examine the outcomes of its anti-coronavirus formulation in children aged 6 months to 2 years this yr.
Vaccination continues in Turkey for these aged 18 and over.
#BioNTech #preparing #apply #vaccinations #children #years
Dikkat: Sitemiz herkese açık bir platform olduğundan, çox fazla kişi paylaşım yapmaktadır. Sitenizden izinsiz paylaşım yapılması durumunda iletişim bölümünden bildirmeniz yeterlidir.